Showing results (151-160 of 205) with videos related to
Sort By:
Pageof 21
Arthritis & Rheumatology (Hoboken, N.J.)|February 27, 2018
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus ModelSonia Zeggar, Katsue S Watanabe, Sanae Teshigawara, et al.Oncology Reports|June 7, 2017
Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cellsEmiko Akashi, Shintaro Fujihara, Asahiro Morishita, et al.Internal Medicine (Tokyo, Japan)|August 2, 2023
Immune Checkpoint Inhibitor-induced Pancreatitis with Pancreatic Enlargement Mimicking Autoimmune Pancreatitis: A Case Report and Review of the LiteratureKiyokuni Tanabe, Kensuke Yokoyama, Atsushi Kanno, et al.Plos One|June 7, 2013
Galectin-9 activates and expands human T-helper 1 cellsMarloes J M Gooden, Valerie R Wiersma, Douwe F Samplonius, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2002
MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancerMichiho Nishioka, Takashi Kohno, Masachika Tani, et al.Journal of Digestive Diseases|July 14, 2012
A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: a clinically aggressive tumorShin Saito, Yoshinori Hosoya, Kazue Morishima, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancersKentaro Inamura, Kengo Takeuchi, Yuki Togashi, et al.Plos One|August 9, 2017
Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment culturesTomoyuki Nakano, Yoshihiko Kanai, Yusuke Amano, et al.AIDS (London, England)|December 2, 2022
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized miceZhe Yuan, Leila B Giron, Colin Hart, et al.British Journal of Pharmacology|March 9, 2005
A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activityKarl Ziegelbauer, Florian Gantner, Nicholas W Lukacs, et al.Pageof 21